New drug tested for Tough-to-Treat blood cancers

NCT ID NCT05475925

Recruiting now Disease control Sponsor: Dren Bio Source: ClinicalTrials.gov ↗

Summary

This is the first study in people to test an experimental drug called DR-01 for adults with rare and aggressive blood cancers, including large granular lymphocytic leukemia (LGLL) and several types of cytotoxic lymphomas. The main goals are to find a safe dose and see if the drug can shrink tumors. The study will enroll about 69 adults whose cancer has come back or hasn't responded to previous treatments.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Dren Investigational Site
RECRUITING

Birmingham, Alabama, 35233, United States

Contact Phone: •••-•••-••••
Dren Investigational Site
RECRUITING

Duarte, California, 91010, United States

Contact Phone: •••-•••-••••
Dren Investigational Site
RECRUITING

Irvine, California, 92612, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Dren Investigational Site
RECRUITING

Redwood City, California, 94063, United States

Contact Phone: •••-•••-••••
Dren Investigational Site
RECRUITING

New Haven, Connecticut, 06519, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Dren Investigational Site
RECRUITING

Tampa, Florida, 33612, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Dren Investigational Site
RECRUITING

Boston, Massachusetts, 02114, United States

Contact Phone: •••-•••-••••
Dren Investigational Site
RECRUITING

Columbus, Ohio, 43210, United States

Contact Phone: •••-•••-••••
Dren Investigational Site
RECRUITING

Houston, Texas, 77030, United States

Contact Phone: •••-•••-••••
Dren Investigational Site
RECRUITING

Charlottesville, Virginia, 22903, United States

Contact Phone: •••-•••-••••
Dren Investigational Site
RECRUITING

Fairfax, Virginia, 22031, United States

Contact Phone: •••-•••-••••
Dren Investigational Site
RECRUITING

Seattle, Washington, 98109, United States

Contact Phone: •••-•••-••••
Dren Investigational Site
RECRUITING

Clayton, Victoria, 3168, Australia

Contact Phone: •••-•••-•••• Email: •••••@•••••
Dren Investigational Site
RECRUITING

Richmond, Victoria, 3121, Australia

Contact Phone: •••-•••-••••
Dren Investigational Site
RECRUITING

Nedlands, Western Australia, 6009, Australia

Contact Phone: •••-•••-••••
Dren Investigational Site
RECRUITING

Pierre-Bénite, 69310, France

Contact Phone: •••-•••-••••
Dren Investigational Site
RECRUITING

Rennes, 35000, France

Contact Phone: •••-•••-••••
Dren Investigational Site
RECRUITING

Toulouse, 31059, France

Contact Phone: •••-•••-••••
Dren Investigational Site
RECRUITING

Berlin, 10117, Germany

Contact Phone: •••-•••-••••
Dren Investigational Site
NOT_YET_RECRUITING

Cologne, 50937, Germany

Contact Phone: •••-•••-••••
Dren Investigational Site
RECRUITING

Leipzig, 04103, Germany

Contact Phone: •••-•••-••••
Dren Investigational Site
RECRUITING

Bologna, 40126, Italy

Contact Phone: •••-•••-••••
Dren Investigational Site
RECRUITING

Goyang-si, South Korea

Contact Phone: •••-•••-••••
Dren Investigational Site
RECRUITING

Barcelona, 08035, Spain

Contact Phone: •••-•••-••••
Dren Investigational Site
RECRUITING

Salamanca, 37007, Spain

Contact Phone: •••-•••-••••
Dren Investigational Site
RECRUITING

Tainan, Taiwan

Contact Phone: •••-•••-••••
Dren Investigational Site
RECRUITING

Taipei, Taiwan

Contact Phone: •••-•••-••••
Dren Investigational Site 1
RECRUITING

New York, New York, 10021, United States

Contact Phone: •••-•••-••••
Dren Investigational Site 1
RECRUITING

Hong Kong, Hong Kong

Contact Phone: •••-•••-••••
Dren Investigational Site 1
RECRUITING

Busan, South Korea

Contact Phone: •••-•••-••••
Dren Investigational Site 1
RECRUITING

Seoul, South Korea

Contact Phone: •••-•••-••••
Dren Investigational Site 2
NOT_YET_RECRUITING

New York, New York, 10032, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Dren Investigational Site 2
RECRUITING

Pittsburgh, Pennsylvania, 15213, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Dren Investigational Site 2
RECRUITING

Hong Kong, Hong Kong

Contact Phone: •••-•••-••••
Dren Investigational Site 2
RECRUITING

Busan, South Korea

Contact Phone: •••-•••-••••
Dren Investigational Site 2
RECRUITING

Seoul, South Korea

Contact Phone: •••-•••-••••
Dren Investigational Site 3
RECRUITING

Seoul, South Korea

Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.

AGGRESSIVE NK CELL LEUKEMIA CUTANEOUS PTCL-NOS (CD8+ OR CD56+ AND CYTOTOXIC MARKER) CYTOTOXIC PTCL-NOS (CD8+ OR CD56+ AND CYTOTOXIC MARKER) ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA EXTRANODAL NK/T CELL LYMPHOMA, NASAL TYPE HEPATOSPLENIC T-CELL LYMPHOMA HYDROA VACCINIFORME-LIKE LYMPHOPROLIFERATIVE DISORDER LGLL - LARGE GRANULAR LYMPHOCYTIC LEUKEMIA MONOMORPHIC EPITHELIOTROPIC INTESTINAL T-CELL LYMPHOMA PRIMARY CUTANEOUS CD8+ AGGRESSIVE EPIDERMOTROPIC T-CELL LYMPHOMA PRIMARY CUTANEOUS GAMMA-DELTA T-CELL LYMPHOMA SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA SYSTEMIC EBV1 T-CELL LYMPHOMA, IF CD8 POSITIVE